Intra-Cellular Therapies Inc (ITCI)
73.26
+1.13
(+1.57%)
USD |
NASDAQ |
Apr 26, 16:00
73.33
+0.07
(+0.10%)
After-Hours: 20:00
Intra-Cellular Therapies Stock Buybacks (Quarterly): 0.00 for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.007M |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | -433.72M |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.00 |
December 31, 2020 | 0.00 |
September 30, 2020 | -375.84M |
June 30, 2020 | 0.11M |
March 31, 2020 | -276.98M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | |
September 30, 2018 |
Date | Value |
---|---|
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | 0.00 |
September 30, 2015 | -327.91M |
June 30, 2015 | 0.00 |
March 31, 2015 | -122.08M |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | -116.19M |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-433.72M
Minimum
Mar 2022
0.11M
Maximum
Jun 2020
-57.18M
Average
--
Median
Jun 2019
Stock Buybacks (Quarterly) Benchmarks
Johnson & Johnson | 216.00M |
Insmed Inc | -114.46M |
Vertex Pharmaceuticals Inc | 152.70M |
Fate Therapeutics Inc | -- |
ADMA Biologics Inc | -- |